Journal of Clinical Trials

Journal of Clinical Trials
Open Access

ISSN: 2167-0870


Journal of Clinical Trials : Citations & Metrics Report

Articles published in Journal of Clinical Trials have been cited by esteemed scholars and scientists all around the world. Journal of Clinical Trials has got h-index 16, which means every article in Journal of Clinical Trials has got 16 average citations.

Following are the list of articles that have cited the articles published in Journal of Clinical Trials.

  2020 2019 2018 2017 2016

Year wise published articles

78 38 20 35 52

Year wise citations received

161 114 125 135 150
Journal total citations count 1047
Journal impact factor 2.76
Journal 5 years impact factor 3.07
Journal cite score 3.14
Journal h-index 16
Journal h-index since 2016 14
Important citations

Ritchey AW, Kuban JD, Sheth RA (2017) Minimally Invasive Therapies for Hepatocellular Carcinoma: Mechanisms of Local Control and Systemic Immunologic Response. InHepatocellular Carcinoma-Advances in Diagnosis and Treatment

Werthmann PG, Kempenich R, Lang-Avérous G, Kienle GS (2019) Long-term survival of a patient with advanced pancreatic cancer under adjunct treatment with Viscum album extracts: A case report. World Journal of Gastroenterology 25:1524.

Schoenberg SO, Attenberger UI, Solomon SB, Weissleder R (2018) Developing a Roadmap for Interventional Oncology 23(10).

Huang S, Qu N, Men Y, Liu Z (2019) Effects of thermal ablation on Treg/Th17 in hepatocellular carcinoma of mice. European Journal of Inflammation.

Liu D, Qi X, Manjunath Y, Kimchi ET, Ma L et al. (2018) Modulating Antitumor Immunity in Hepatocellular Cancer. Journal of immunology research and therapy 3:115.

Tan W, Sun W, Li X, Zhao L, Wang C et al. (2018) Preablation neutrophil-to-lymphocyte ratio as an independent prognostic factor in locally advanced hepatocellular carcinoma patients following radiofrequency ablation. Journal of cancer research and therapeutics 14:84.

Lewandowski RJ, Salem R (2018) Microwave or radiofrequency ablation: clinically equivalent. The Lancet Gastroenterology and Hepatology 3:291-292.

Pickhardt PJ (2018) CT colonography provides new insights into interval cancers. The Lancet Gastroenterology & Hepatology 3:292-294.

Qi X, Lam SS, Liu D, Kim DY, Ma L (2016) Development of InCVAX, in situ cancer vaccine, and its immune response in mice with hepatocellular cancer. Journal of clinical & cellular immunology 7.

Hickey RM, Kulik LM, Nimeiri H, Kalyan A, Kircher S (2017) Immuno-oncology and its opportunities for interventional radiologists: immune checkpoint inhibition and potential synergies with interventional oncology procedures. Journal of Vascular and Interventional Radiology 28:1487-1494.

De Cesare A, Caselli E, Lucchi A, Sala C, Parisi A et al. (2019) Impact of a probiotic-based cleaning product on the microbiological profile of broiler litters and chicken caeca microbiota. Poultry Science

La Fauci V, Costa GB, Genovese C, Palamara MA, Alessi V (2019) Drug-resistant bacteria on hands of healthcare workers and in the patient area: an environmental survey in Southern Italy’s hospital. Revista Española de Quimioterapia 32:303.

Baid A (2016) ELISA-A mini review Res Rev J Pharm Anal 5:1-8.

D’Accolti M, Soffritti I, Mazzacane S, Caselli E (2019) Fighting AMR in the healthcare environment: Microbiome-based sanitation approaches and monitoring tools. International journal of molecular sciences 20:1535.

Caselli E (2017) Hygiene: microbial strategies to reduce pathogens and drug resistance in clinical settings. Microbial biotechnology 10:1079-1083.

Burns KE, Rizvi L, Cook DJ, Seely AJ, Rochwerg B et al. (2019) Frequency of Screening and SBT Technique Trial-North American Weaning Collaboration (FAST-NAWC): a protocol for a multicenter, factorial randomized trial. Trials 20:587.

O'Connor JM, Sharma M, Singareddy A (2019) Development of methods to evaluate probability of reviewer’s assessment bias in Blinded Independent Central Review (BICR) imaging studies. InMedical Imaging 2019: Image Perception, Observer Performance, and Technology Assessment. International Society for Optics and Photonics 10952:109520.

Beaumont H, Evans TL, Klifa C, Guermazi A, Hong SR (2018) Discrepancies of assessments in a RECIST 1.1 phase II clinical trial–association between adjudication rate and variability in images and tumors selection. Cancer Imaging 18:50.

Ellingson BM On the promise of artificial intelligence for standardizing radiographic response assessment in gliomas.

Sharma M, O'Connor JM, Singareddy A (2019) Reader disagreement index: a better measure of overall review quality monitoring in an oncology trial compared to adjudication rate. InMedical Imaging 2019: Image Perception, Observer Performance, and Technology Assessment. International Society for Optics and Photonics 10952:109520.

Relevant Topics